Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions

Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Aug 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a method called the Transversus Abdominis Plane (TAP) block to help manage pain during certain heart procedures, like coronary angiography and cardiac catheterization. The TAP block aims to numb specific nerves in the lower abdomen to make these procedures more comfortable for patients. The researchers also want to see how satisfied both patients and doctors are with this pain management approach during the procedures.

To take part in this study, participants must be at least 18 years old and scheduled for one of the heart procedures mentioned above. They should not be in an emergency situation and must not have severe obesity, be pregnant, or have certain serious health conditions. If someone decides to join the study, they can expect to receive the TAP block to help with pain relief, and their experience will be monitored to ensure everything goes smoothly. This trial is currently looking for volunteers, and it's important for potential participants to understand the eligibility criteria and to give their consent to be part of the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The patient is over 18 years of age
• • Coronary angiography, cardiac catheterization and percutaneous coronary intervention will be applied to the patient,
• • The above-mentioned procedures will be taken under elective conditions,
• • Providing an optimal image when imaging the patient with ultrasound,
• • INR\< 1.5
• • If the patient gives consent, S/he will be included in the study.
• Exclusion Criteria:
• • Patients under 18 years of age,
• • Patients treated under emergency conditions,
• • morbid obesity (BMI\>35 kg/m2),
• • pregnant women,
• • New York Heart Association (NYHA) stage 4 patients with advanced decompensated heart failure,
• • Patients with symptoms such as redness, temperature increase, infection, hematoma in the application area before the procedure,
• • Patients with a history of allergy to local anesthetics,
• • Patients who cannot be communicated,
• • Those with severe psychosis or progressive neurological deficits and muscle disease,
• • Patients who do not consent to the application will be excluded from the study.